LobbyingArthritis Foundation lobbying by quarter
Arthritis Foundation's latest lobbying report covers Q2 2026, at $75K. The four quarters Q4 2025–Q3 2026 total $225K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.
Arthritis Foundation
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $225K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $75K | 1 |
| Q1 2023 | $75K | 1 |
| Q2 2023 | $75K | 1 |
| Q3 2023 | $200K | 1 |
| Q4 2023 | $75K | 1 |
| Q1 2024 | $75K | 1 |
| Q2 2024 | $75K | 1 |
| Q3 2024 | $75K | 1 |
| Q4 2024 | $75K | 1 |
| Q1 2025 | $75K | 1 |
| Q2 2025 | $75K | 1 |
| Q3 2025 | $75K | 1 |
| Q4 2025 | $75K | 1 |
| Q1 2026 | $75K | 1 |
| Q2 2026 | $75K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$416.7K · 15 reports
- Health issues$416.7K · 15 reports
- Medicare and Medicaid$416.7K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Disease Control & Prevention (CDC)15 reports
- Centers For Medicare and Medicaid Services (CMS)15 reports
- Defense, Dept of (DOD)15 reports
- Food & Drug Administration (FDA)15 reports
- Health & Human Services, Dept of (HHS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- Natl Institutes of Health (NIH)15 reports
- SENATE15 reports
- Veterans Affairs, Dept of (VA)15 reports
- Labor, Dept of (DOL)14 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseArthritis Foundation | $1.3M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALISA VIDULICH CASAVANT | Policy Director | Q2 2026 |
| ANNA HYDE | Vice President, Advocacy and Access | Q2 2026 |
| HAYLEY DEMPSEY | Federal Affairs Manager | Q2 2026 |
| CHARLES HUSSER jr | Federal Affairs Manager | Q2 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/14for Q2 | In-house | $75K |
| 04/20for Q1 | In-house | $75K |
| 01/20for Q4 2025 | In-house | $75K |
| 25/10/20for Q3 2025 | In-house | $75K |
| 25/07/17for Q2 2025 | In-house | $75K |
| 25/04/18for Q1 2025 | In-house | $75K |
| 25/01/21for Q4 2024 | In-house | $75K |
| 24/10/18for Q3 2024 | In-house | $75K |
| 24/07/19for Q2 2024 | In-house | $75K |
| 24/04/19for Q1 2024 | In-house | $75K |
| 24/04/04for Q1 2024 | In-house | $75K |
| 24/01/17for Q4 2023 | In-house | $75K |
| 23/10/16for Q3 2023 | In-house | $200K |
| 23/07/19for Q2 2023 | In-house | $75K |
| 23/04/20for Q1 2023 | In-house | $75K |
| 23/01/20for Q4 2022 | In-house | $75K |